With Covid-19 almost waning, Indian pharma companies are struggling with the excess stock of key drugs…
Tag: central drugs standard control organisation
Covaxin Booster Jabs Trial Shows ‘Long-Term Safety With No Adverse Events’: Bharat Biotech
New Delhi: The trial of Covaxin booster jabs has demonstrated “long-term safety with no serious adverse…
covid: Media reports on expired Covid vaccines being used in India false, misleading: Health ministry | India News – Times of India
NEW DELHI: The Union health ministry on Monday dismissed media reports alleging that expired vaccines are…
EXPLAINED: As India Clears SII’s Covovax, Know How This Nanoparticle-Based Vaccine Works
New Delhi: After an expert panel of the Central Drugs Standard Control Organisation (CDSCO) recommended granting…
CDSCO Recommends Vaccine Corbevax & Anti-Covid Pill Molnupiravir With Caveat: Report
New Delhi: An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended…
bharat biotech: Bharat Biotech seeks nod for phase-3 trials of intranasal Covid-19 vaccine as booster dose | India News – Times of India
HYDERABAD: Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials…